| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,116 | 1,596 | 1,242 | 1,382 | | Cost of Revenue | 461 | 1,572 | 945 | 1,565 | | | Gross Profit | 654 | 24 | 297 | (183) | | | Operating Expenses | | Research Development | 442 | 417 | 461 | 464 | | Selling General and Administrative | (918) | 434 | (115) | 570 | | Non Recurring |
-
| (234) | 234 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 151 | (594) | (284) | (1,217) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 1 | 1,026 | 224 | | Earnings Before Interest And Taxes | 97 | (593) | 742 | (993) | | Interest Expense | (18) | 9 | 9 | 374 | | Income Before Tax | 115 | (602) | 733 | (1,367) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (864) | (602) | 733 | (1,367) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 115 | (602) | 733 | (1,367) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $115 | ($602) | $733 | ($1,367) |
|
0.51% Nasdaq 
Income Statement
